Autophagy activation upon anti-cancer therapy may result in cancer cell protection contributing to drug resistance and breast cancer progression via PI3K/AKT/mTOR, ERK, p53, Vascular Endothelial Growth Factor (VEGF), EGFR, and MAPK14/p38α signaling [154,155,156,157]. The gene discussed is MAPK1; the disease is cancer.